See more : North Mining Shares Company Limited (0433.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Onassis Holdings Corp. (ONSS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Onassis Holdings Corp., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Denkyo Group Holdings Co.,Ltd. (8144.T) Income Statement Analysis – Financial Results
- BioPlus Acquisition Corp. (BIOS) Income Statement Analysis – Financial Results
- SNT Motiv Co., Ltd. (064960.KS) Income Statement Analysis – Financial Results
- Khiron Life Sciences Corp. (KHRN.V) Income Statement Analysis – Financial Results
- Kachchh Minerals Limited (KACHCHH.BO) Income Statement Analysis – Financial Results
Onassis Holdings Corp. (ONSS)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.onassis-holdings.com
About Onassis Holdings Corp.
Onassis Holdings Corp. focuses on the wellness, cannabidiol (CBD) and hemp oil, and cosmetics industries. The company provides various products and services to businesses operating in the CBD and hemp oil industry in the United States and Europe. It also develops and markets electronic disinfection devices. The company was formerly known as Onassis Mining Group, Inc. and changed its name to Onassis Holdings Corp. in September 2019. Onassis Holdings Corp. is headquartered in New York, New York.
| Metric | 2023 | 2022 | 2021 | 2019 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 6.78K | 53.40K | 0.00 | 18.36M | 15.86M | 14.79M | 12.23M | 8.26M | 3.82M | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 11.20M | 9.06M | 8.37M | 8.71M | 6.95M | 7.07K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 6.78K | 53.40K | 0.00 | 7.16M | 6.79M | 6.43M | 3.52M | 1.31M | 3.81M | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 100.00% | 100.00% | 0.00% | 39.02% | 42.83% | 43.46% | 28.81% | 15.84% | 99.81% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 18.00K | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 182.46K | 168.03K | 449.28K | 100.00K | 4.79M | 4.58M | 3.81M | 2.47M | 963.49K | 1.58M | 18.00K | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -4.88M | -1.84M | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 182.46K | 168.03K | 449.28K | 100.00K | 4.79M | 4.58M | 3.81M | 2.47M | 963.49K | 3.42M | 18.00K | 12.50K | 20.00K | 45.15K |
| Cost & Expenses | 182.46K | 168.03K | 449.28K | 100.00K | 15.98M | 13.64M | 12.18M | 11.18M | 7.91M | 3.43M | 18.00K | 12.50K | 20.00K | 45.15K |
| Interest Income | 0.00 | 0.00 | 0.00 | 2.76K | 682.66 | 310.00 | 89.00 | 94.00 | 946.00 | 291.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 33.89K | 29.21K | 55.59K | 0.00 | 0.00 | 691.00K | 927.52K | 1.47M | 217.91K | 10.91K | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 167.90K | 228.49K | 236.56K | 171.86K | -1.82K | -396.91K | 64.36K | 619.33K | 72.10K | 7.07K | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA | -182.46K | -161.25K | -395.89K | -100.00K | 1.82M | 1.48M | 2.68M | 1.68M | 417.43K | 404.78K | -18.00K | -12.50K | -20.00K | -45.15K |
| EBITDA Ratio | 0.00% | -2,380.07% | -741.44% | 0.00% | 8.13% | 11.46% | 18.11% | 13.66% | 5.06% | 10.37% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -182.46K | -161.25K | -395.89K | -100.00K | 2.37M | 2.21M | 2.62M | 1.05M | 344.38K | 388.57K | -18.00K | -12.50K | -20.00K | -45.15K |
| Operating Income Ratio | 0.00% | -2,380.07% | -741.44% | 0.00% | 12.93% | 13.97% | 17.67% | 8.60% | 4.17% | 10.18% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -33.89K | -29.21K | -55.59K | 2.76K | -1.24M | -1.03M | -1.11M | -1.46M | -216.96K | -1.77K | 18.00K | 12.50K | 20.00K | 45.15K |
| Income Before Tax | -216.35K | -190.46K | -451.47K | -97.24K | 1.13M | 1.18M | 1.51M | -412.60K | 127.42K | 386.80K | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | 0.00% | -2,811.28% | -845.53% | 0.00% | 6.18% | 7.47% | 10.18% | -3.37% | 1.54% | 10.14% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -167.90K | -228.49K | -236.56K | -171.86K | 143.50K | 277.95K | 128.04K | 126.85K | -69.35K | 121.49K | 18.00K | 12.50K | 20.00K | 45.15K |
| Net Income | -216.35K | -190.46K | -451.47K | -97.24K | 990.31K | 906.00K | 1.38M | -539.45K | 196.77K | 265.31K | -18.00K | -12.50K | -20.00K | -45.15K |
| Net Income Ratio | 0.00% | -2,811.28% | -845.53% | 0.00% | 5.39% | 5.71% | 9.31% | -4.41% | 2.38% | 6.95% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | 0.00 | 0.85 | -0.48 | 0.24 | 0.32 | -0.51 | -0.36 | -0.01 | -0.02 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | 0.00 | 0.85 | -0.48 | 0.24 | 0.32 | -0.51 | -0.36 | -0.01 | -0.02 |
| Weighted Avg Shares Out | 127.91M | 122.02M | 121.68M | 110.65M | 21.40M | 421.81M | 1.62M | 1.12M | 831.99K | 819.00K | 35.00K | 35.00K | 2.68M | 2.41M |
| Weighted Avg Shares Out (Dil) | 127.91M | 122.02M | 121.68M | 110.65M | 21.40M | 421.81M | 1.62M | 1.12M | 831.99K | 819.00K | 35.00K | 35.00K | 2.71M | 2.41M |
Onassis Holdings Retained Investment Bank Dalmore Group to Launch up to $75 Million Regulation A+ Offering (Mini IPO)
Onassis Enters Agreement for International Shares Distribution
Source: https://incomestatements.info
Category: Stock Reports